FindTrial
Sign In

Shanghai Clinical Cohort – Inflammatory Bowel Disease (Demonstration)

Shanghai Clinical Cohort – Inflammatory Bowel Disease (Demonstration)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110099
Enrollment
Unknown
Registered
2025-09-30
Start date
2025-09-30
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease

Interventions

Observation group:None

Sponsors

Shanghai Jiaotong University School of Medicine, Renjl Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Inflammatory bowel disease patients aged 18-75 years old; 2.Admitted patients, whether newly diagnosed or assessed; 3.Agree to sign an informed consent form.

Exclusion criteria

Exclusion criteria: After examination, the diagnosis of inflammatory bowel disease was ruled out.

Design outcomes

Primary

MeasureTime frame
HBI score;SCCDAI score;—

Secondary

MeasureTime frame
IBDQ;MAYO score;SES-CD score;—

Countries

China

Contacts

Public ContactFang Jingyuan

Shanghai Jiao Tong University School of Medicine,Renji Hospital

fangjingyuan_new@163.com+86 21 6838 3104

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026